Androgen Receptor
AR (androgen receptor) is a member of steroid hormone receptor and ligand-activated transcription factor. It plays a crucial role in prostate cellular proliferation and male sexual differentiation.
Products for Androgen Receptor
- Cat.No. Product Name Information
-
GC45239
δ4-Abiraterone
CB 7627, D4A
δ4-Abiraterone is a major metabolite of abiraterone. δ4-Abiraterone is an inhibitor of CYP17A1, 3b-hydroxysteroid dehydrogenase (3βHSD) and steroid-5a-reductase (SRD5A) and also an antagonist of androgen receptor. -
GC61491
(R)-Bicalutamide
(R)-Bicalutamide is the (R)-enantiomer of Bicalutamide. (R)-Bicalutamide is an androgen receptor (AR) antagonist, with antineoplastic activity. (R)-Bicalutamide is widely used for the research of prostate cancer.
-
GC73509
(R)-SKBG-1
(R)-SKBG-1 is an RNA-binding protein NONO inhibitor.
-
GC30710
(R)-UT-155
(R)-UT-155 (compound 11) is a selective androgen receptor degrader (SARD) ligand. Less active than the S-isomer.
-
GC63292
(rac)-PF-998425
(Rac)-PF-998425 is a potent, selective, nonsteroidal androgen receptor (AR) antagonist.
-
GC49520
(S)-Equol
4',7Dihydroxyisoflavan, (-)Equol, 4',7Isoflavandiol
An estrogen receptor β agonist
-
GC40528
11α-hydroxy Testosterone
11α-hydroxy Testosterone is a metabolite of testosterone, produced by the cytochrome P450 (CYP) isoform CYP3A.
-
GC46456
16α-Hydroxyetiocholanolone
A metabolite of 16α-DHEA and androstenedione
-
GC17557
17 alpha-propionate
CB-03-01
A peripherally selective androgen receptor antagonist -
GC41300
17β-hydroxy Exemestane
17β-hydroxy Exemestane is the primary active metabolite of exemestane.
-
GC46471
17β-hydroxy Exemestane-d3
A neuropeptide with diverse biological activities
-
GC35069
2,2,5,7,8-Pentamethyl-6-Chromanol
2,2,5,7,8-Pentamethyl-6-Chromanol (PMC) is the anti-oxidant moiety of vitamin E (α-tocopherol). 2,2,5,7,8-Pentamethyl-6-Chromanol has potent androgen receptor (AR) signaling modulation and anti-cancer activity against prostate cancer cell lines.
-
GC17160
2-hydroxy Flutamide
Hydroxyniphtholide,SCH 16423
2-hydroxy Flutamide (HF), an active metabolite of Flutamide, is a potent androgen receptor antagonist (IC50=700 nM). 2-hydroxy Flutamide can be used for the research of prostate cancer. -
GC12791
3,3'-Diindolylmethane
DIM
A phytochemical with antiradiation and chemopreventative effects -
GC49542
5α-Androstan-3β-ol
NSC 50887
A steroidal androgen -
GC48808
5β-Androstane-3α,17β-diol
5β-Adiol, 5β-Androstanediol, β-Androstane-3α,17β-diol, Etiocholanediol
A metabolite of testosterone -
GC49827
5-Androstenetriol
Δ5-AT
An active metabolite of DHEA -
GC15774
5α-dihydro-11-keto Testosterone
5α-Androstane-3,11-dione-17β-ol,11-keto Dihydrotestosterone,17β-hydroxy-5α-Androstane-3,11-dione
5α-dihydro-11-keto Testosterone (11-KDHT; 5α-Dihydro-11-keto testosterone) is an endogenous steroid and a metabolite of 11β-Hydroxyandrostenedione. -
GC19458
6β-hydroxy Testosterone
4-Androsten-6β,17β-diol-3-one, 6β, 17β,-Dihydroxyandrost-4-en-3-one
CYP3A4 and CYP3A5 are cytochrome P450 enzymes whose expression is induced by glucocorticoids and certain xenobiotics, including many drugs and chemical carcinogens. -
GC49391
7α-Thiospironolactone
Deacetylspironolactone, Mercaptospironolactone, SC-24813, 7α-Thio-SL
An active metabolite of spironolactone -
GC63764
7-α-Methylthio Spironolactone-D3
-
GC48880
7-Methoxyflavone
A flavone with diverse biological activities
-
GC46775
Abiraterone Acetate-d4
CB-7630-d4
A neuropeptide with diverse biological activities -
GC46777
AC-262536
A selective androgen receptor modulator
-
GC31738
ACP-105
ACP-105 is an orally available, selective amd potent androgen receptor modulator (SARM), with pEC50s of 9.0 and 9.3 for AR wild type and T877A mutant, respectively.
-
GC67703
Adrenocorticotropic hormone TFA
ACTH TFA; Adrenocorticotrophic hormone TFA
-
GC68630
AH3960
AH3960 (compound 16c) is a androgen receptor antagonist. AH3960 can bind to both wild-type and T877 mutant androgen receptors, selectively inhibiting T877 (IC50=0.82 μM). AH3960 is also an agonist of the parathyroid hormone receptor PTHR1.
-
GC31742
Ailanthone (δ13-Dehydrochaparrinone)
Δ13-Dehydrochaparrinone
Ailanthone (δ13-Dehydrochaparrinone) (δ13-Dehydrochaparrinone) is a potent inhibitor of both full-length androgen receptor (AR) (IC50=69nM) and constitutively active truncated AR splice variants (AR1-651 IC50=309nM). -
GC13685
Andarine
Andarine, S-4, SARM S-4
Andarine (S-4) is an orally active and selective nonsteroidal androgen receptor (AR) modulator (SARM) and a partial agonist, with Ki of 4 nM. Andarine (S-4) is identified as SARMs with potent and tissue-selective in vivo pharmacological activity. -
GC67698
Androgen receptor-IN-2
-
GC73577
Androgen receptor-IN-6
Androgen receptor-IN-6 (compound 16) is an orally available androgen receptor (Androgen Receptor) potent inhibitor (IC50=0.12 μM in vitro), targeting the disordered N-terminal domain (NTD).
-
GC31254
Androst-4-ene-3,17-diol, dipropanoate, (3β,17β)- (Androst-4-ene-3β,17β-diol, dipropionate)
-
GC34887
Androstanolone acetate
-
GC60589
Apalutamide D4
ARN-509-d4
Apalutamide D4 (ARN-509 D4) is a deuterium labeled Apalutamide. Apalutamide is a potent and competitive androgen receptor (AR) antagonist, binding AR with an IC50 of 16 nM. -
GC64540
Ar-V7-IN-1
Ar-V7-IN-1 is a potent inhibitor of Ar-V7. AR-V7 is a hormone-independent splice variant of the androgen receptor. Ar-V7-IN-1 has the potential for the research of various indications, in particular cancers such as prostate cancer (extracted from patent WO2018114781A1, compound 43).
-
GC73613
ARD-1676
ARD-1676 is an orally available androgen receptor (AR) PROTAC degrader, consisting of AR ligand and cereblon ligand.
-
GC73277
ARD-2051
ARD-2051 is a potent and orally active androgen receptor (AR) proteolysis-targeting chimera degrader.
-
GC72850
ARD-69
ARD-69 (compound 34) is a potent PROTAC androgen receptor degrader.
-
GC16840
ARN-509
ARN 509; ARN509
ARN-509 (ARN-509) is a potent and competitive androgen receptor (AR) antagonist, binding AR with an IC50 of 16 nM. -
GC62118
ARV-110
ARV-110
ARV-110 (ARV-110) is an orally active, specific androgen receptor (AR) PROTAC degrader. ARV-110 promotes ubiquitination and degradation of AR. ARV-110 can be used for the research of prostate cancer. -
GC10547
ASC-J9
A selective enhancer of AR degradation
-
GC66207
Atraric acid
Methyl atrarate
Atraric acid (Methyl atrarate) is a specific androgen receptor (AR) antagonist with anti-inflammatory and anticancer effects. Atraric acid represses the expression of the endogenous prostate specific antigen gene in both LNCaP and C4-2 cells. Atraric acid can also inhibit the synthesis of NO and cytokine, and suppress the MAPK-NFκB signaling pathway. Atraric acid can be used to research prostate diseases and inflammatory diseases. -
GC10372
AZD3514
Androgen receptor downregulator
-
GC12271
Bicalutamide
ICI 176334, ZD 176334
Androgen receptor antagonist -
GC46925
Bicalutamide-d4
An internal standard for the quantification of bicalutamide
-
GC31577
Bifluranol (BX341)
BX341
Bifluranol (BX341) (BX341) is an anti-androgen. -
GC35534
BMS-564929
BMS-564929 is an androgen receptor (AR) agonist, binds to androgen receptor (AR) with a Ki of 2.11±0.16 nM.
-
GC41187
Boldenone Cypionate
Boldenone is an anabolic androgenic steroid and synthetic derivative of testosterone that was originally developed for veterinary use.
-
GC35541
Boldenone Undecylenate
Boldenone 10-Undecenoate
-
GC73237
BWA-522
BWA-522 is an orally available small molecule protein-targeting chimera (PROTACs) with significant degradation effect on AR-FL and AR-V7.
-
GC17491
CITCO
Constitutive androstane receptor (CAR) agonist
-
GC14560
Cl-4AS-1
steroidal androgen receptor agonist
-
GC62209
CLP-3094
CLP-3094 is a potent BF3 (binding function 3)-directed inhibitor of the androgen receptor (AR).
-
GC47159
Cyprodinil
An anilinopyrimidine fungicide
-
GC13971
Cyproterone Acetate
CPA, Cyprostat, NSC 81430, SH 714
Androgen receptor antagonist -
GC10785
Danazol
Danocrine,Ladogal,NSC 270916,WIN 17,757
A derivative of testosterone and ethisterone -
GC11070
Dehydroepiandrosterone (DHEA)
Androstenolone, trans-Dehydroandrosterone, DHEA, Diandrone, NSC 9896, Prasterone, Psicosterone
Dehydroepiandrosterone (DHEA) and its sulfate ester, DHEAS, together represent the most abundant steroid hormones in the human body . -
GC34005
Dehydroisoandrosterone 3-acetate (Dehydroepiandrosterone 3-acetate)
Dehydroepiandrosterone 3-acetate is a testosterone/estrogen precursor and known modulator of vertebrate aggression.
-
GC47215
Dienogest-d8
An internal standard for the quantification of dienogest
-
GC47231
Dimethomorph
A morpholine fungicide
-
GC31441
DJ-V-159
DJ-V-159 is an agonist for G protein-coupled receptor family C group 6 member A (GPRC6A).
-
GC49648
Enobosarm-d4
(S)-Enobosarm-d4
An internal standard for the quantification of enobosarm -
GC64854
Enzalutamide-d3
Enzalutamide D3 is a deuterium labeled Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells.
-
GC69072
Enzalutamide-d6
MDV3100-d6
Enzalutamide-d6 is a deuterium-labeled Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cancer cells.
-
GC16631
EPI-001
AR antagonist
-
GC73291
EPI-7170
EPI-7170, a ralaniten analogue, is a potent androgen receptor N-terminal structural domain antagonist that blocks the transcriptional activity of full-length AR (FL-AR) and AR splice variants (AR-Vs).
-
GC13072
Epiandrosterone
5α-Androstan-3β-ol-17-one, Isoandrosterone, trans-Androsterone, NSC 93996
steroid hormone with weak androgenic activity -
GC11796
Estradiol valerate
Estradiol 17β-valerate, NSC 17590
Estradiol valerate (β-estradiol 17-valerate) is a synthetic estrogen widely used in combination with other steroid hormones in hormone replacement therapy drugs. -
GC49563
Fenhexamid
KBR 2738
Fenhexamid, a botryticide, is a sterol biosynthesis inhibitor. -
GC10618
Fluoxymesterone
NSC 10704, NSC 12165
androgen receptor agonist -
GC12126
Flutamide
Niftolide, NSC 147834, NSC 251876, SCH 13521
Androgen receptor antagonists -
GC48831
Flutamide-d7
SCH 13521-d7
An internal standard for the quantification of flutamide -
GC90891
Furosine (hydrochloride)
An L-lysine derivative
-
GC74031
GA32
GA32 (compound 58r) is potent androgen receptor (AR)/glucocorticoid receptor (GR) dual inhibitor with IC50 values of 0.13 μM and 0.83 μM for AR and GR, respectively.
-
GC49303
Ganoderic Acid DM
A triterpenoid with diverse biological activities
-
GC30086
GLPG0492
A selective androgen receptor modulator
-
GC30101
GLPG0492 R enantiomer
GLPG0492 R enantiomer is the R enantiomer of GLPG-0492, which is a novel selective androgen receptor modulator.
-
GC17679
GSK2881078
selective androgen receptor modulator (SARM)
-
GC69200
Gumelutamide
Gumelutamide is a tetrahydropyridine and pyrimidine compound that acts as an anti-androgen and anti-tumor agent. Gumelutamide is an androgen receptor antagonist.
-
GC14221
HE-3235
Apoptone,17α-Ethynyl-5α-androstane-3α,17ß-diol
HE-3235, synthetic analogue of 3β-androstanediol, is an orally bioavailable anticancer agent. HE-3235 is active in rodent models of prostate and breast cancer. -
GC62249
Honokiol DCA
Honokiol dichloroacetate
-
GC36344
Isosilybin B
Isosilybin B, a flavonolignan isolated from silymarin, has anti-prostate cancer (PCA) activity via inhibiting proliferation and inducing G1 phase arrest and apoptosis. Isosilybin B causes androgen receptor (AR) degradation.
-
GC62106
JNJ-63576253
TRC-253
JNJ-63576253 (TRC-253) is a potent and orally active full antagonist of androgen receptor (AR), with IC50s of 37 and 54 nM for F877L mutant AR and wild-type AR in LNCaP cells. JNJ-63576253 can be used for the research of castration-resistant prostate cancer (CRPC). -
GC92094
KISS1-305 (trifluoroacetate salt)
D-Tyr-D-Pya(4)-Asn-Ser-Phe-azaGly-Leu-Arg(Me)-Phe-NH2
KISS1-305 is a peptide agonist of the kisspeptin receptor. -
GC18496
Leelamine (hydrochloride)
Dehydroabietylamine
Leelamine is a diterpene molecule whose name derives from the Sanskrit word leela which means 'play'- It has weak affinity for the human central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, exhibiting 20% displacement of [3H]-CP55940 at a concentration of 10 uM. -
GC47554
Letrozole-d4
An internal standard for the quantification of letrozole
-
GC32403
LGD-3303
LGD-3303 is a selective androgen receptor modulator (SARM).
-
GC32408
LGD-4033
An Analytical Reference Standard
-
GC61971
Liarozole
R 75251
Liarozole (R75251; R85246) is an imidazole derivative and orally active retinoic acid (RA) metabolism-blocking agent (RAMBA). -
GC63579
Linuron
Linuron is a phenylurea herbicide that is widely used to control the growth of grass and weeds in various agriculture crops and in orchards.
-
GN10142
Lupeol
Clerodol, Fagarasterol, Lupenol, Monogynol B, NSC 90487, βViscol
-
GC31380
LY2452473
LY2452473 is an orally bioavailable, selective androgen receptor modulator (SARM).
-
GC12385
MDV3100 (Enzalutamide)
Enzalutamide
MDV3100(enzalutamide) is a second-generation AR antagonist with an IC50 of 36nM in LNCaP prostate cells. -
GC12974
Medroxyprogesterone acetate
NSC 21171, NSC 26386, U-8839
Medroxyprogesterone acetate (MPA) is a synthetic progestin. -
GC61850
Medroxyprogesterone acetate D3
-
GC62061
Melengestrol acetate
MGA, NSC 70968
Melengestrol acetate is a progesterone derivative, acts as an orally active corticosteroid hormone to promote endometrial proliferation, pregnancy maintenance, and delay of menstrual activity. -
GC63066
Methenolone acetate
-
GC11837
MI-136
menin-MLL interaction inhibitor
-
GC47674
Mifepristone-d3
RU486-d3; RU 38486-d3
A neuropeptide with diverse biological activities -
GC36621
MK-0773
PF-05314882
MK-0773 is a selective androgen receptor modulators (SARMs) that binds to AR with an IC50 of 6.6 nM.